Keyphrases
Intensive Care Unit Patients
100%
Scoping Review
95%
Randomized Clinical Trial
77%
Days Alive without Life Support
74%
International Networks
71%
Adaptive Clinical Trials
68%
Critical Care
67%
COVID-19
62%
Health-related Quality of Life
60%
Septic Shock
59%
Critical Care Trials
49%
Predictive Enrichment
47%
Hydroxychloroquine
47%
Trial Protocol
47%
Adult Patients
47%
Adult Intensive Care Unit
44%
Intensive Care Unit
42%
Root Mean Square Error
41%
Clinical Trials
39%
Intravenous Fluids
38%
Adaptive Trial Design
37%
Healthcare Data
35%
Individualized Prediction
35%
Methodological Considerations
33%
Binary Outcome
31%
Rheumatoid Arthritis
30%
Adaptive Trial
29%
Patient Characteristics
29%
Heterogeneous Treatment Effects
28%
Adaptive Randomization
28%
Methodological Choices
27%
Intensive Care Unit Admission
27%
Patient Outcomes
27%
Event Counts
27%
Patient Data
27%
Intravenous Fluid Therapy
26%
Fluid Restriction
26%
Sepsis
26%
Critical Illness
26%
Hyperlactatemia
23%
Randomized Trial
23%
Bayesian Analysis
23%
Restrictive Fluid Therapy
23%
Between-day
23%
Antipsychotics
23%
Count Outcomes
23%
Prediction Window
23%
Bi-center
23%
Antipsychotic-induced Weight Gain
23%
Cytochrome P450 2D6 (CYP2D6)
23%
Medicine and Dentistry
Intensive Care Unit
84%
Intensive Care
76%
Quality of Life
68%
COVID-19
65%
Cohort Analysis
49%
Hydroxychloroquine
47%
Rheumatoid Arthritis
47%
Septic Shock
47%
Randomized Clinical Trial
47%
Adverse Event
35%
Arm
35%
Clinical Trial
34%
Infusion Fluid
32%
Hazard Ratio
32%
Sepsis
29%
Intravenous Drug Administration
26%
Critical Illness
26%
Treatment Effect
25%
Phenotype
23%
Fluid Therapy
23%
Health Care
23%
Meropenem
23%
Intensive Care Medicine
23%
Noradrenalin
23%
Secondary Data
23%
Post-Hoc Analysis
23%
Monte Carlo Method
23%
Retrospective Study
23%
Azithromycin
23%
Hyperlactatemia
23%
Piperacillin/Tazobactam
23%
Randomized Controlled Trial
17%
Effect Size
13%
All Cause Mortality
11%
Attributable Risk
10%
Proportional Hazards Model
9%
Electronic Patient Record
9%
Adaptive Response
9%
Lactic Acid
8%
Hyperglycemia
7%
Rheumatology
7%
Hypoglycemia
7%
Drug Megadose
7%
Statistical Analysis
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Tartaric Acid
6%
Base
6%
Cardiovascular Mortality
6%
Glycemic Control
5%
Drug Therapy
5%
